Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

57
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
57
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

426
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

652
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
652
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

698
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
698

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-sectional study exploring the prevalence and associated risk factors for suicidality among apprentices in the Irish construction industry.

BMJ public health·2026
Same author

A decade of discovery: Leveraging genomic data in the ABCD study to illuminate adolescent neurodevelopment.

Developmental cognitive neuroscience·2026
Same author

"We are more than just a number": Mental health needs in the context of diabetes healthcare in Ireland.

HRB open research·2026
Same author

Comparison of <i>Galleria mellonella</i>, Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure <i>Pseudomonas aeruginosa</i> Virulence.

bioRxiv : the preprint server for biology·2026
Same author

Transformations in Diabetes Care: Lessons From Commons-Based, Peer-Produced Citizen Science.

Sociology of health & illness·2026
Same author

Where is the social in the psychosocial? A narrative review.

Diabetic medicine : a journal of the British Diabetic Association·2025

Related Experiment Video

Updated: Mar 20, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K

Improving Pediatric Medication Safety Through Implementation of Evidence-Based Guidelines.

Maia Dorsett1, Shane O'Donnell2, Ward Strickland3

  • 1Department of Emergency Medicine, University of Rochester Medical Center, Rochester, New York.

Prehospital Emergency Care
|March 18, 2026
PubMed
Summary
This summary is machine-generated.

Pediatric medication dosing errors in emergency medical services (EMS) were reduced by implementing standardized weight estimation, volume-based dosing tools, and clinician training. This quality improvement initiative achieved 97% correct dosing for initial pediatric medications.

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K

Related Experiment Videos

Last Updated: Mar 20, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K

Area of Science:

  • Emergency medicine
  • Pediatric critical care
  • Quality improvement science

Background:

  • Pediatric medication dosing errors are prevalent in prehospital settings, especially during critical events.
  • Weight-based calculations pose a significant challenge for accurate dosing.
  • Evidence-based guidelines recommend standardized weight estimation, volume-based dosing, cognitive offload tools, and clinician training.

Purpose of the Study:

  • To implement evidence-based guidelines across an emergency medical services (EMS) system.
  • To achieve at least 95% correct dosing for initial pediatric medication administration.
  • To reduce medication errors in pediatric emergency care.

Main Methods:

  • A quality improvement initiative guided by the Model for Improvement was conducted in an EMS system.
  • Interventions included a volume-based dosing application, standardized length-based weight estimation, and hands-on training.
  • Performance was monitored using Shewhart p-charts and Individual (I) charts, with ongoing case review for iterative improvements.

Main Results:

  • Baseline dosing accuracy was 79% (2020-2022), with midazolam for seizures being the most frequent error (65% correct).
  • Median correct dosing increased to 91% post-implementation, with sustained improvement to 97% by December 2025.
  • Targeted retraining and application redesign enhanced accuracy, particularly for route-specific dosing.

Conclusions:

  • Improving pediatric medication safety in EMS necessitates a comprehensive, collaborative, and iterative quality management approach.
  • Sustained high performance requires continuous monitoring, targeted interventions, and system-level collaboration.
  • Effective implementation of evidence-based tools, coupled with robust quality infrastructure, ensures reliable and durable improvements in pediatric medication safety.